Clinical Trial Update: Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Crisaborole 2% ointment in mild to moderate atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole Ointment (2%) (crisaborole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Atopic Dermatitis | Phase 4 | Status: UNKNOWN